02/11/2025
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
8:30 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
5:04 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
6:46 PM | Lipocine (Issuer)
Patel Mahesh V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
6:47 PM | Lipocine (Issuer)
Patel Mahesh V. (Reporting)
| Form 4/A | |
12/30/2024
7:03 PM | Fogarty Krista (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
7:04 PM | Lipocine (Issuer)
Patel Mahesh V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
5:06 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
8:45 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for LPCN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. |
11/07/2024
5:09 AM | Lipocine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
3:37 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:05 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
5:04 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
8:30 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
8:39 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
8:35 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
10:23 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
5:19 AM | Lipocine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
5:20 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:15 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
7:15 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:39 PM | Fink Jeffrey Arvin (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:41 PM | Higuchi John W. (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:43 PM | Jene Jill M. (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:45 PM | Lipocine (Issuer)
Ono Richard Dana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:48 PM | Lipocine (Issuer)
Papapetropoulos Spyros (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:32 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
4:15 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:03 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:06 AM | Lipocine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
5:15 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
8:00 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Lipocine (Filer)
| Form 424B5 | |
04/26/2024
4:20 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Collect $7k per month from Tesla’s SECRET dividend (Ad) There's a little-known secret about Tesla that even seasoned investors don't know.
Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month.
This backdoor strategy is changing the game for smart investors.
Want to see how it works? Click here to uncover Tesla's hidden income secret. |
04/25/2024
11:15 PM | Lipocine (Filer)
| Form EFFECT | |
04/23/2024
3:24 PM | Lipocine (Filer)
| Form S-3/A | |
04/23/2024
3:05 PM | Lipocine (Filer)
| Form DEF 14A | |
04/11/2024
6:24 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
5:26 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
5:14 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
4:51 PM | Fogarty Krista (Reporting)
Lipocine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
4:53 PM | Lipocine (Issuer)
Patel Mahesh V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:31 PM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
5:07 AM | Lipocine (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
5:08 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:01 AM | Lipocine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
